Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium.

Standard

Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. / Schächinger, Volker; Aicher, Alexandra; Döbert, Natascha; Röver, Rainer; Diener, Jürgen; Fichtlscherer, Stephan; Assmus, Birgit; Seeger, Florian H; Menzel, Christian; Brenner, Winfried; Dimmeler, Stefanie; Zeiher, Andreas M.

In: CIRCULATION, Vol. 118, No. 14, 14, 2008, p. 1425-1432.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Schächinger, V, Aicher, A, Döbert, N, Röver, R, Diener, J, Fichtlscherer, S, Assmus, B, Seeger, FH, Menzel, C, Brenner, W, Dimmeler, S & Zeiher, AM 2008, 'Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium.', CIRCULATION, vol. 118, no. 14, 14, pp. 1425-1432. <http://www.ncbi.nlm.nih.gov/pubmed/18794392?dopt=Citation>

APA

Schächinger, V., Aicher, A., Döbert, N., Röver, R., Diener, J., Fichtlscherer, S., Assmus, B., Seeger, F. H., Menzel, C., Brenner, W., Dimmeler, S., & Zeiher, A. M. (2008). Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. CIRCULATION, 118(14), 1425-1432. [14]. http://www.ncbi.nlm.nih.gov/pubmed/18794392?dopt=Citation

Vancouver

Schächinger V, Aicher A, Döbert N, Röver R, Diener J, Fichtlscherer S et al. Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. CIRCULATION. 2008;118(14):1425-1432. 14.

Bibtex

@article{2b59c8c841ea4a48856232371197f089,
title = "Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium.",
abstract = "BACKGROUND: Clinical trials indicate a beneficial effect of intracoronary infusion of progenitor cells on myocardial function in patients with ischemic heart disease. The extent and potential determinants of proangiogenic progenitor cell homing into the damaged myocardium after intracoronary infusion and the underlying mechanisms are still unknown. METHOD AND RESULTS: Circulating proangiogenic progenitor cells isolated from peripheral blood and cultivated for 3 days were labeled with radioactive indium oxine ((111)In-oxine). Radiolabeled proangiogenic progenitor cells (7.6+/-3.0 MBq, mean+/-SD) were administered to patients with previous myocardial infarction and a revascularized infarct vessel at various stages after infarction (5 days to 17 years). Viability of the infarcted myocardium was determined by (18)F-fluorodeoxyglucose-positron emission tomography and microcirculatory function by intracoronary Doppler measurements. One hour after application of progenitor cells, a mean of 6.9+/-4.7% (range, 1% to 19%; n=17) of total radioactivity was detected in the heart, which declined to 2+/-1% after 3 to 4 days. Average activity within the first 24 hours was highest among patients with acute myocardial infarction (14 days to 1 year; 4.5+/-3.2%; n=4) or a chronic stage (infarct age >1 year; 2.5+/-1.6%; n=5). Low viability of the infarcted myocardium and reduced coronary flow reserve were significant (P",
author = "Volker Sch{\"a}chinger and Alexandra Aicher and Natascha D{\"o}bert and Rainer R{\"o}ver and J{\"u}rgen Diener and Stephan Fichtlscherer and Birgit Assmus and Seeger, {Florian H} and Christian Menzel and Winfried Brenner and Stefanie Dimmeler and Zeiher, {Andreas M}",
year = "2008",
language = "Deutsch",
volume = "118",
pages = "1425--1432",
journal = "CIRCULATION",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "14",

}

RIS

TY - JOUR

T1 - Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium.

AU - Schächinger, Volker

AU - Aicher, Alexandra

AU - Döbert, Natascha

AU - Röver, Rainer

AU - Diener, Jürgen

AU - Fichtlscherer, Stephan

AU - Assmus, Birgit

AU - Seeger, Florian H

AU - Menzel, Christian

AU - Brenner, Winfried

AU - Dimmeler, Stefanie

AU - Zeiher, Andreas M

PY - 2008

Y1 - 2008

N2 - BACKGROUND: Clinical trials indicate a beneficial effect of intracoronary infusion of progenitor cells on myocardial function in patients with ischemic heart disease. The extent and potential determinants of proangiogenic progenitor cell homing into the damaged myocardium after intracoronary infusion and the underlying mechanisms are still unknown. METHOD AND RESULTS: Circulating proangiogenic progenitor cells isolated from peripheral blood and cultivated for 3 days were labeled with radioactive indium oxine ((111)In-oxine). Radiolabeled proangiogenic progenitor cells (7.6+/-3.0 MBq, mean+/-SD) were administered to patients with previous myocardial infarction and a revascularized infarct vessel at various stages after infarction (5 days to 17 years). Viability of the infarcted myocardium was determined by (18)F-fluorodeoxyglucose-positron emission tomography and microcirculatory function by intracoronary Doppler measurements. One hour after application of progenitor cells, a mean of 6.9+/-4.7% (range, 1% to 19%; n=17) of total radioactivity was detected in the heart, which declined to 2+/-1% after 3 to 4 days. Average activity within the first 24 hours was highest among patients with acute myocardial infarction (14 days to 1 year; 4.5+/-3.2%; n=4) or a chronic stage (infarct age >1 year; 2.5+/-1.6%; n=5). Low viability of the infarcted myocardium and reduced coronary flow reserve were significant (P

AB - BACKGROUND: Clinical trials indicate a beneficial effect of intracoronary infusion of progenitor cells on myocardial function in patients with ischemic heart disease. The extent and potential determinants of proangiogenic progenitor cell homing into the damaged myocardium after intracoronary infusion and the underlying mechanisms are still unknown. METHOD AND RESULTS: Circulating proangiogenic progenitor cells isolated from peripheral blood and cultivated for 3 days were labeled with radioactive indium oxine ((111)In-oxine). Radiolabeled proangiogenic progenitor cells (7.6+/-3.0 MBq, mean+/-SD) were administered to patients with previous myocardial infarction and a revascularized infarct vessel at various stages after infarction (5 days to 17 years). Viability of the infarcted myocardium was determined by (18)F-fluorodeoxyglucose-positron emission tomography and microcirculatory function by intracoronary Doppler measurements. One hour after application of progenitor cells, a mean of 6.9+/-4.7% (range, 1% to 19%; n=17) of total radioactivity was detected in the heart, which declined to 2+/-1% after 3 to 4 days. Average activity within the first 24 hours was highest among patients with acute myocardial infarction (14 days to 1 year; 4.5+/-3.2%; n=4) or a chronic stage (infarct age >1 year; 2.5+/-1.6%; n=5). Low viability of the infarcted myocardium and reduced coronary flow reserve were significant (P

M3 - SCORING: Zeitschriftenaufsatz

VL - 118

SP - 1425

EP - 1432

JO - CIRCULATION

JF - CIRCULATION

SN - 0009-7322

IS - 14

M1 - 14

ER -